Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Ryan Specialty Holdings (RYAN) over the last 6 years, with Q4 2025 value amounting to $158.3 million.

  • Ryan Specialty Holdings' Cash & Equivalents fell 7069.21% to $158.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $158.3 million, marking a year-over-year decrease of 7069.21%. This contributed to the annual value of $158.3 million for FY2025, which is 7069.21% down from last year.
  • Ryan Specialty Holdings' Cash & Equivalents amounted to $158.3 million in Q4 2025, which was down 7069.21% from $153.5 million recorded in Q3 2025.
  • In the past 5 years, Ryan Specialty Holdings' Cash & Equivalents registered a high of $2.0 billion during Q2 2023, and its lowest value of $153.5 million during Q3 2025.
  • In the last 5 years, Ryan Specialty Holdings' Cash & Equivalents had a median value of $1.1 billion in 2021 and averaged $1.0 billion.
  • In the last 5 years, Ryan Specialty Holdings' Cash & Equivalents skyrocketed by 39309.09% in 2021 and then plummeted by 9010.44% in 2025.
  • Ryan Specialty Holdings' Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then soared by 55.08% to $1.8 billion in 2022, then plummeted by 52.54% to $838.8 million in 2023, then plummeted by 35.6% to $540.2 million in 2024, then tumbled by 70.69% to $158.3 million in 2025.
  • Its Cash & Equivalents stands at $158.3 million for Q4 2025, versus $153.5 million for Q3 2025 and $172.6 million for Q2 2025.